A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma. [electronic resource]
Producer: 20131219Description: 96 p. digitalISSN:- 1477-7819
- Adenocarcinoma -- drug therapy
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Crown Ethers -- administration & dosage
- DNA-Binding Proteins -- genetics
- Deoxycytidine -- administration & dosage
- Endonucleases -- genetics
- Female
- Follow-Up Studies
- Humans
- Induction Chemotherapy
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Pilot Projects
- Prognosis
- Quinazolines -- administration & dosage
- RNA, Messenger -- genetics
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Ribonucleoside Diphosphate Reductase
- Tumor Suppressor Proteins -- genetics
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.